KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Gains from Investment Securities (2016 - 2026)

Medtronic's Gains from Investment Securities history spans 13 years, with the latest figure at $1.8 billion for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities rose 230.84% to $1.8 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $1.9 billion, a 263.48% increase, with the full-year FY2025 number at $249.0 million, down 4.6% from a year prior.
  • Gains from Investment Securities hit $1.8 billion in Q1 2026 for Medtronic, up from -$292.0 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for MDT hit a ceiling of $1.8 billion in Q1 2026 and a floor of -$1.4 billion in Q1 2024.
  • Historically, Gains from Investment Securities has averaged $269.0 million across 5 years, with a median of $154.0 million in 2022.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 3944.12% in 2024 and later surged 1288.89% in 2025.
  • Tracing MDT's Gains from Investment Securities over 5 years: stood at -$408.0 million in 2022, then skyrocketed by 343.38% to $993.0 million in 2023, then surged by 33.53% to $1.3 billion in 2024, then tumbled by 122.02% to -$292.0 million in 2025, then skyrocketed by 704.45% to $1.8 billion in 2026.
  • Business Quant data shows Gains from Investment Securities for MDT at $1.8 billion in Q1 2026, -$292.0 million in Q4 2025, and $125.0 million in Q3 2025.